AMEH:NSD-Apollo Medical Holdings Inc (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 49.61

Change

0.00 (0.00)%

Market Cap

USD 2.25B

Volume

0.25M

Avg Analyst Target

USD 57.00 (+14.90%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


AMEH Stock Forecast & Price:
Based on the Apollo Medical Holdings Inc stock forecasts from 1 analysts, the average analyst target price for Apollo Medical Holdings Inc is USD 57.00 over the next 12 months. Apollo Medical Holdings Inc’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Apollo Medical Holdings Inc is Slightly Bullish , which is based on 5 positive signals and 4 negative signals. At the last closing, Apollo Medical Holdings Inc’s stock price was USD 49.61. Apollo Medical Holdings Inc’s stock price has changed by -8.81% over the past week, +11.89% over the past month and -35.18% over the last year.

About Apollo Medical Holdings Inc (AMEH:NSD)

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-08-14 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ACHC Acadia Healthcare Company Inc

N/A

USD7.50B 26.82 16.08
LHCG LHC Group

N/A

USD5.07B 68.93 29.77
ENSG The Ensign Group Inc

N/A

USD4.76B 23.99 17.63
AMED Amedisys Inc

N/A

USD3.97B 28.59 16.20
SGRY Surgery Partners Inc

N/A

USD3.39B 63.00 14.33
PRSC The Providence Service Corpora..

N/A

USD2.21B 74.23 15.08
TVTY Tivity Health Inc

N/A

USD1.62B 19.06 12.00
ADUS Addus HomeCare Corporation

N/A

USD1.52B 33.84 19.95
HCSG Healthcare Services Group Inc

N/A

USD1.10B 38.05 17.06
DCGO DocGo Inc

N/A

USD0.95B 24.76 17.93

ETFs Containing AMEH

Symbol Name Weight Mer Price(Change) Market Cap
IWC iShares Micro-Cap ETF 0.00 % 0.60 %

N/A

USD1.05B
PTH Invesco DWA Healthcare Mo.. 0.00 % 0.60 %

N/A

USD0.25B
XSMO Invesco S&P SmallCap Mome.. 0.00 % 0.39 %

N/A

USD0.16B

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -32.49% 36% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -32.49% 36% F 33% F
Trailing 12 Months  
Capital Gain -35.18% 58% F 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -35.18% 58% F 37% F
Trailing 5 Years  
Capital Gain 451.22% 86% B 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 451.22% 86% B 95% A
Average Annual (5 Year Horizon)  
Capital Gain 72.35% 85% B 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 72.35% 85% B 93% A
Risk Return Profile  
Volatility (Standard Deviation) 131.24% 25% F 9% F
Risk Adjusted Return 55.13% 70% C- 86% B
Market Capitalization 2.25B 77% C+ 79% C+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 30.62 53% F 29% F
Price/Book Ratio 4.83 23% F 20% F
Price / Cash Flow Ratio 31.94 14% F 10% F
EV/EBITDA 76.24 14% F 3% F
Management Effectiveness  
Return on Equity -0.38% 41% F 50% F
Return on Invested Capital 11.52% 78% C+ 78% C+
Return on Assets 6.75% 86% B 86% B
Debt to Equity Ratio 40.24% 53% F 44% F
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 21.10 9% F 2% F
Short Percent 20.14% 5% F 8% F
Beta 0.69 67% D+ 74% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.